Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gallardo

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Journal of Personality|March 27, 2015
The World at 7:00: Comparing the Experience of Situations Across 20 CountriesEsther Guillaume, Erica Baranski, Elysia Todd, et al.
Leukemia & Lymphoma|August 20, 2013
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic SyndromesBlanca Xicoy, María-José Jiménez, Olga García, et al.
JAMA|February 18, 2019
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical TrialGlenn Hernández, Gustavo A Ospina-Tascón, Lucas Petri Damiani, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Journal of Personality|March 27, 2015
The World at 7:00: Comparing the Experience of Situations Across 20 CountriesEsther Guillaume, Erica Baranski, Elysia Todd, et al.
Leukemia & Lymphoma|August 20, 2013
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic SyndromesBlanca Xicoy, María-José Jiménez, Olga García, et al.
JAMA|February 18, 2019
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical TrialGlenn Hernández, Gustavo A Ospina-Tascón, Lucas Petri Damiani, et al.
Pageof 11